Biotechnology Sector - Biotech Research

DEC 19 - Amgen Inc, the world's largest biotechnology company, and generic drugmaker Watson Pharmaceuticals Inc, said on Monday they will work together to develop and sell biosimilar versions of several biotech cancer drugs.The companies, which plan to sell biosimilar products under ...

(Reuters) - Apple Inc named long-serving director Arthur Levinson chairman of its board, filling a seat vacated by co-founder Steve Jobs, who died in October after a years-long struggle with cancer.Walt Disney Co CEO Bob Iger, who had a strong relationship with ...

(Reuters) - Biogen Idec Inc's multiple sclerosis drug met the main goal of a closely watched clinical study, the biotechnology company said on Wednesday.Biogen said the results of the Confirm Phase III study showed that BG-12, administered either twice a day or ...

NEW YORK (Reuters) - When scientists at Genentech and parent Roche need to discuss business, they do not talk to each other -- they use lawyers.Roche acquired the remaining stake of Genentech it did not already own in 2009, against the protests ...

(Reuters) - Immunomedics Inc said on Thursday that the U.S. health regulator put a partial hold on the company's pancreatic cancer drug trial after a patient was given an incorrect dose.Immunomedics, which develops antibody-based products for treatment of cancer, autoimmune and other ...

This as a drug delivery stock popped on a new submission to the FDA Monday'+company+ ' (TSX: '+exchange+'.'+symbol+', Stock Forum)'+percent+'Stockhouse Canadian Small and Micro-cap Stock Report for Monday, May 16, 2011 TORONTO (SHfn) – Encanto Potash (TSX: V.EPO, Stock Forum) shares climbed ...

With the market in a trendless, highly correlated pattern, we have to move into unconventional areas to find excellent risk/reward setups right nowIn the past six months or so, I've spilled a lot of "ink" writing about the high correlation between stocks, ...

LOS ANGELES (Reuters) - Amgen Inc , whose cash balance has soared even as its core anemia drug franchise erodes, will outline its strategy -- and likely announce its first dividend -- at a meeting on Thursday with Wall Street.The world's largest ...

PARIS (Reuters) - French drugmaker Sanofi-Aventis completed its improved $20.1 billion offer for Genzyme, allowing it to begin merging the U.S. biotech firm into its business and add rare diseases to its growth areas.Sanofi said 84.6 percent of Genzyme's common stock had ...

Previous

1
2
3
4
5
6
7
8
9
10

Topic: Biotechnology Sector

Amgen, Watson to collaborate on cancer biosimilars

Amgen,Watson to collaborate on cancer biosimilars

Apple names Levinson chair; Disney CEO joins board

Biogen multiple sclerosis drug works in second trial

Roche, Genentech researchers avoid business talk

FDA puts Immunomedics cancer drug trial on hold

Junior explorer jumps on potash resource projection

Why the recent breakout in this sector is important

Amgen to outline strategy at investor meeting

Sanofi-Aventis says completes offer for Genzyme

Photo Gallery

From Around the Web

Video Gallery

Follow this Topic with...